Back to results
US 2011/0034515 A1Published application
Indole modulators of the alpha 7 nicotinic acetylcholine receptor
AssigneeProximagen Limited
InventorsKevin Dinnell, Andrew P. Lightfoot, Howard Robert Marshall
Life of this patent
Estimating the term…
Abstract
This invention relates to modulation of the α7 nicotinic acetylcholine receptor (nAChR) by a compound of formula (I) or a salt thereof
Claims12
A compound of formula (I) or a salt thereof:
- wherein:
- R1 is hydrogen or C1-3alkyl;
- R2 is hydrogen, halo or cyano;
- and
- R3 is group
- wherein Ra is halo, C1-6alkyl, C1-6alkoxy, haloC1-6alkyl, haloC1-6alkoxy or cyano.
3 more elements
A compound which is:
- N-[(2-trifluoromethyl-1H-indol-5-yl)methyl]-5-(trifluoromethyl)-2-pyridinecarboxamide;
- N-[(2-trifluoromethyl-1H-indol-5-yl)methyl]-5-(2,2,2-trifluoroethoxy)-2-pyridinecarboxamide;
- 6-bromo-N-{[2-(trifluoromethyl)-1H-indol-5-yl]methyl}-3-pyridinecarboxamide;
- 6-cyano-N-{[2-(trifluoromethyl)-1H-indol-5-yl]methyl}-3-pyridinecarboxamide;
- N-[(2-trifluoromethyl-7-bromo-1H-indol-5-yl)methyl]-5-(trifluoromethyl)-2-pyridinecarboxamide;
- N-[(2-trifluoromethyl-7-cyano-1H-indol-5-yl)methyl]-5-(trifluoromethyl)-2-pyridinecarboxamide;
- N-[(1-methyl-2-trifluoromethylindol-5-yl)methyl]-5-(trifluoromethyl)-2-pyridinecarboxamide;
- or
- a salt thereof.
6 more elements
A compound which is N-[(2-Trifluoromethyl-1H-indol-5-yl)methyl]-5-(trifluoromethyl)-2-pyridinecarboxamide.
7-13. (canceled)
Dependencies are inferred from the claim text.